The ARCS/BFS COVID Group met yesterday to consider the Joint Guidelines. We have agreed an addendum to version 3 taking into account the likely discussions with patients around vaccination and fertility treatment in light of the Joint Committee on Vaccination and Immunisation priority advice relating to the Pfizer - BioNTech vaccine published on 2nd December. The addendum may be updated as advice changes and incorporated into future versions of the guidance. On behalf of the Executive Committees of both societies the Group invite our members to comment on the Guidelines and in particular any new areas of concern or practice which you feel should be included or addressed differently. In particular we are interested in your experience of so-called long COVID - in terms of either repeat screening or perhaps more importantly any observed effects in your patients, male or female. Review the addendum here. Thank you as ever for your support and help in this. We wish you well for the Festive period however altered that might be for you - health and happiness to those around you. Jason Kasraie Chair ARCS Jane Stewart Chair British Fertility Society
